Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
Article in Translational Lung Cancer Research (August 2020)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Translational Lung Cancer Research (August 2020)
Article in Clinical Cancer Research (July 2020)
Article in International Journal of Molecular Sciences (January 2020)